+65 9177 1375
[email protected]
Home
About Us
Founder Story
What We Do
Our Products
Respiratory & Pulmonary Diagnostics
Neonatal & Critical Care
Neurology Solutions
Cardiology Solutions
Sleep Diagnostics
Articles
The Role of DLCO in Assessing Pulmonary Gas Transfer
Our Brands
Contact Us
home
>
Our Products
>
Respiratory & Pulmonary Diagnostics
>
EucapSys*
EucapSys*
Please enter valid quantity.
WhatsApp
Email
Product Description
The eucapnic voluntary hyperpnea (EVH) test is an alternative to other indirect or direct bronchial provocation tests, such as the methacholine challenge test1.
Innovative, patented technology facilitates the generation of a hypercapnic air mixture. As a result, EucapSys reduces gas-related costs by 90%.
Improved patient comfort
Drug free with dry air
Higher specificity: Fewer false results
Lower operation costs
EucapSys – Bronchial Provocation without medication.
The EVH test is an alternative method to other indirect or direct bronchial challenge tests such as exercise challenge or metacholine challenge test1.
The huge advantage of EVH is that no medication is needed. Traditionally it has been used for elite athletes2 and is widely regarded as the gold standard for assessing exercise induced bronchoconstriction (EIB) among athletes3.
As EVH mimicries perfectly the breathing while exercising, the provocative method is the best tool to diagnose exercise-induced airway narrowing. EucapSys is the first commercially available system which makes EVH applicable for a wide range of users. As it mixes the eucapnic gas concentration by itself, the test becomes more affordable and independent from expensive gas mixtures.
Measurement Principle
1. PRE spirometry test
Before doing the provocation, a forced spirometry sets the baseline for pre FEV1.
2. EucapSys test
Then, a dry gas mixture enriched with 5 % CO2 is hyperventilated at room temperature for about six minutes through a breathing mask. The patient will breathe faster than normally through a mouthpiece. The maneuver is recorded to the EucapSys system box.
1. PRE spirometry test
After the provokational phase, the post measurements are carried out. If the value falls below 10% of the baseline FEV1, an asthma can be diagnosed.
Benefits at a glance
Economical
: The EucapSys reduces gas-related costs by
90%
. Gas supply is thus facilitated and guaranteed.
Operation
: Using a non-expensive air cylinder and CO2 cylinder, EucapSys produces the hypercapnic mixture you need. An innovative patented technology helps to produce a hypercapnic air mixture gradually and according to your needs, for up to 200 l/min.
CO2-Content
: Dynamically regulated at 5% in order to be isocapnic, that is equivalent to 40 mmHg of PetCO2.
Application
: Athletes; scuba divers; fire fighters; persons, who complain about breathlessness after activity; confirmation of asthma diagnosis in difficult cases
Frequently Purchase Together
PowerCube Ergo
SpiroScout
PowerCube Diffusion+
PowerCube Body+